ArticlemedRxiv : the preprint server for health sciences2025
Identifying Sex-Specific Sub-phenotypes of Alzheimer's Disease Progression Using Longitudinal Electronic Health Records.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
11 authors.
Funding
Abstract
Alzheimer's Disease (AD) is a complex neurodegenerative disorder strongly influenced by sex differences, with women comprising nearly two-thirds of cases. However, sex-specific progression patterns remain underexplored due to unclear clinical and molecular mechanisms. To address this gap, we developed a temporal autoencoder framework to identify sex-specific AD sub-phenotypes using longitudinal electronic health record (EHR) data from the OneFlorida+ Clinical Research Consortium. Sequential EHRs were encoded into latent representations and clustered to derive disease states, which were assembled into progression pathways. This approach uncovered five primary sex-stratified sub-phenotypes with distinct trajectories and phenotypic characteristics. Survival and cumulative prevalence analyses further revealed heterogeneous temporal dynamics of AD onset and comorbidity accumulation between female- and male-dominant groups. By integrating deep learning with large-scale real-world data, our framework advances understanding of sex-based heterogeneity in AD progression and provides a scalable tool for early risk stratification, personalized intervention, and improved clinical trial design.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.